View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Regulatory Globe
23 March 2021

Swiss-Authorised Representative

A signed mutual recognition agreement (MRA) between the EU and Switzerland by 26 May 2021 does not seem conceivable anymore. This means Switzerland will become a third-party country where Swiss manufacturers need an EU-authorised representative to export their products into the EU. On the other hand, manufacturers in the EU will need a Swiss-authorised representative to import their products into Switzerland.

This leads to an unsettling situation for many importers, distributors and manufacturers. We at Regulatory Globe and EUmediq are specialised to act as EU and Swiss-authorised representative and we are happy to support you in this matter. Get in contact with Regulatory Globe or EUmediq so we can answer your questions and, if desired, support you as your authorised representative.

For manufacturers who are not established in the Union, the EU Authorised Representative plays a pivotal role in ensuring the compliance of the devices produced...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy